EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition

Tsz Kin Suen, Burcu Al, Thomas Ulas, Nico Reusch, Harsh Bahrar, Siroon Bekkering, Jaydeep Bhat, Dieter Kabelitz, Joachim L Schultze, Frank L van de Veerdonk, Jeanine Roeters van Lennep, Niels P Riksen und 3 weitere

Immunology · 2025

DOI: 10.1111/imm.13931 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Tsz Kin Suen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Mevalonic Acid, Receptors, Antigen, T-Cell, gamma-delta, T-Lymphocytes, Intraepithelial Lymphocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch HEart Foundation/Dutch Cardiovascular Alliance, German Research Foundation (DFG), the grant number is EXC2151/1 ImmunoSensation2-the Immune Sensory System, German Research Foundation (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vδ2 T cells, a predominant human peripheral γδ T cell population, are a promising candidate for the development of immunotherapies against cancer and infected cells. Aminobisphosphonate drugs, such as zoledronate, are commonly used to expand Vδ2 T cells. Yet, such in vitro generated cells have limited efficacy in the clinic. We found that despite inducing excessive proliferation of Vδ2 T cells, zoledronate impaired their effector function and caused the upregulation of the inhibitory receptor TIM3. This effect was due to the inhibition of mevalonate metabolism and dysregulation of downstream biological processes such as protein prenylation and intracellular signalling. In vitro and in vivo inhibition of mevalonate metabolism with zoledronate, statins, and 6‐fluoromevalonate, as well as genetic deficiency of the mevalonate kinase, all resulted in compromised cytokine and cytotoxic molecule production by Vδ2 T cells. Impaired Vδ2 T cell function was accompanied by transcriptome and kinome changes. Our findings reveal the importance of mevalonate metabolism for the proper functioning of Vδ2 T cells. This observation provides important considerations for improving their therapeutic use and has repercussions for patients with statin or aminobisphosphonate treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mevalonic AcidReceptors, Antigen, T-Cell, gamma-deltaT-LymphocytesIntraepithelial LymphocytesHumansZoledronic AcidSignal TransductionAnimalsMevalonate Kinase DeficiencyCells, CulturedLymphocyte ActivationPhosphotransferases (Alcohol Group Acceptor)Hydroxymethylglutaryl-CoA Reductase InhibitorsDiphosphonatesMiceCytokinesCell ProliferationProtein PrenylationHepatitis A Virus Cellular Receptor 2

Stichwörter der Autor:innen

T cellcytokinesflow cytometryhumanprotein kinases/phophatases

Substanzen

Mevalonic AcidZoledronic AcidReceptors, Antigen, T-Cell, gamma-deltamevalonate kinasePhosphotransferases (Alcohol Group Acceptor)Hydroxymethylglutaryl-CoA Reductase InhibitorsHAVCR2 protein, humanDiphosphonatesCytokinesHepatitis A Virus Cellular Receptor 2

Autor:innen und Institutionen

  • Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, Bonn, Germany.
  • Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • PRECISE Platform for Single Cell Genomics and Epigenomics at the DZNE and the University of Bonn, Bonn, Germany.
  • Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Institute of Immunology, University of Kiel, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.

ORCID-Profile: Katarzyna Placek

Förderung

  • Dutch HEart Foundation/Dutch Cardiovascular Alliance
  • German Research Foundation (DFG), the grant number is EXC2151/1 ImmunoSensation2-the Immune Sensory System
  • German Research Foundation (DFG)
  • European Comission" the program is "Horizon 2020 Research and Innovation Program Under the MArie Sklodowska-Curie
  • Dutch Cardiovascular Alliance
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Suen, T. K., Al, B., Ulas, T., Reusch, N., Bahrar, H., Bekkering, S., Bhat, J., Kabelitz, D., Schultze, J. L., van de Veerdonk, F. L., van Lennep, J. R., Riksen, N. P., Joosten, L. A. B., Netea, M. G., & Placek, K. (2025). Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition. Immunology. https://doi.org/10.1111/imm.13931

Vancouver

Suen TK, Al B, Ulas T, Reusch N, Bahrar H, Bekkering S, et al. Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition. Immunology. 2025. doi:10.1111/imm.13931

BibTeX
@article{Suen2025,
  author = {Suen, Tsz Kin and Al, Burcu and Ulas, Thomas and Reusch, Nico and Bahrar, Harsh and Bekkering, Siroon and Bhat, Jaydeep and Kabelitz, Dieter and Schultze, Joachim L and van de Veerdonk, Frank L and van Lennep, Jeanine Roeters and Riksen, Niels P and Joosten, Leo A B and Netea, Mihai G and Placek, Katarzyna},
  title = {Human γδ T Cell Function Is Impaired Upon Mevalonate Pathway Inhibition},
  journal = {Immunology},
  year = {2025},
  doi = {10.1111/imm.13931}
}
Kostenlos starten →